Mounjaro®
Starting from £179.99/mo
Start journey Learn moreTirzepatide in the UK doesn't come in a bottle at all. Each Mounjaro KwikPen is a pre-filled, single-use injector containing four weekly doses, so one pen covers a full month of treatment. The pen format is sealed and ready to use; there's no vial, no syringe-drawing, and no measuring. Because Mounjaro is a prescription-only medicine, a prescriber determines which strength is right for you before any pen is dispensed — the format alone won't tell you what dose you should be on.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Open a Mounjaro KwikPen and you'll find a compact auto-injector roughly the size of a thick marker pen. Inside the cartridge sits the full month's supply: four pre-set doses, each delivered once weekly. Nothing is loose. Nothing needs to be drawn up. The pen simply keeps count as you work through it, and when all four doses are used, the pen is done.
The design is deliberate. Eli Lilly built the KwikPen to remove the variables that come with traditional vial-and-syringe systems, measuring errors, air bubbles, contamination risk. For patients at home, that matters. You press, the pen injects the correct amount, and you're finished. The size of a Mounjaro syringe is a common question for exactly this reason: most people expect a conventional needle and are surprised to find a compact auto-injector instead.
Storage is straightforward: keep the pen in the fridge at 2–8 °C until you need it, then allow it to reach room temperature before injecting. The exact window for how long it can stay out of the fridge is detailed in the Patient Information Leaflet that comes with your pen; follow that rather than any generalised advice online, since the window differs from what you might have read for other injectable medicines.
Tirzepatide is licensed in the UK at six strengths: 2.5, 5, 7.5, 10, 12.5 and 15 mg. The pen itself looks the same at every dose. What changes is the concentration of tirzepatide in the cartridge, not the pen's physical dimensions. This is why a 15 mg pen is no larger than a 2.5 mg pen, both hold four doses, both fit in the same fridge door shelf, both inject in the same way.
Treatment normally begins at 2.5 mg. That first strength exists to give the body time to adjust, reducing the chance of nausea and other gastrointestinal effects in the early weeks. A prescriber then reviews progress and guides titration through higher doses, typically in four-week steps. The full overview of tirzepatide, including how the dual GIP and GLP-1 receptor mechanism works, covers why titration is done gradually.
For anyone reading about cost at different dose levels, the Eli Lilly UK price increase context is worth understanding: Lilly raised UK list prices from 1 September 2025, with higher doses seeing the largest increases. That context is useful when comparing private providers, though it shouldn't be the only factor you weigh.
Searches for a tirzepatide bottle often come from people who've seen compounded semaglutide or research-grade peptides sold in vials online. Those products are different in every meaningful way. A genuine Mounjaro pen is manufactured to a pharmaceutical standard, carries MHRA authorisation, and arrives through the licensed UK supply chain. A vial of unlicensed compound sold without a prescription is none of those things.
The MHRA has warned publicly and repeatedly about fake weight-loss injectable products circulating online, some of which have contained insulin rather than the stated medicine. If you've come across references to a tirzepatide bottle and wondered whether that format is legitimate, it is worth knowing that genuine UK-licensed tirzepatide is only supplied as a pen, never a vial, and any seller offering it otherwise is a red flag. You can check whether any online pharmacy supplying you is registered at the GPhC pharmacy register. Suspect sellers can be reported at the MHRA Yellow Card portal.
There's a separate question about the relationship between lemon bottle products and Mounjaro that comes up frequently. Lemon bottle is an entirely different injectable product; it is not tirzepatide and is not licensed for weight management as a medicine.
Because Mounjaro is a prescription-only medicine, the format of the pen is only one part of what you're arranging. The other part is clinical oversight: a prescriber who reviews your health history, confirms eligibility, and monitors your progress. A pharmacist friend once described the pen as the easy part, what you're really choosing is who's looking after you while you use it.
At nume, every consultation is read by a GPhC-registered Independent Prescriber on the day it's submitted, not processed by an automated queue. Pens are dispensed by our own GPhC-registered pharmacy (registration 9012878, verifiable at the GPhC register) and arrive with DPD, tracked, the next working day in plain unbranded packaging. Order before 12pm and the pen is usually on its way before the afternoon is out.
If you'd like to explore weight-loss treatment options more broadly, or check eligibility, the Mounjaro treatment page walks through the licensed criteria. For any specific questions after reading, our FAQs cover the queries our prescribers see most often.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.